Elicio Therapeutics Inc. (ELTX) Live Share Price, Invest From India

Elicio Therapeutics Inc. Stock Performance

as on July 23, 2026 at 4:13 am IST

Day's Low
Day's High
$2.96
Day's Price Range
$3.18
$3.05
2.95%
Downside
4.26%
Upside
52 Week's Low
52 Week's High
$2.66
52-Week Price Range
$16.00
$3.05
12.79%
Downside
424.59%
Upside

Elicio Therapeutics Inc. share price movements today

Previous Close: $3.08
Open: $3.08
Volume: 290.4K
Day's Low - High: $2.96 - $3.18
52 Week Low - High: $2.66 - $16.00

Elicio Therapeutics Inc. Historical Returns

1 Month Return: -25.6 %
3 Month Return: -74.29 %
1 Year Return: -66.95 %
3 Year Return: -69.05 %
5 Year Return: 0 %

Elicio Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Elicio Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$79.8M

EPS (TTM)

-2.0675

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-37.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-1076.34%

Elicio Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Elicio Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Elicio Therapeutics Inc.	BUY	$79.8M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$38.4B	539.31%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.0B	145.89%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.5B	15.05%	16.53	29.65%	0.53%

Stock Returns calculator for Elicio Therapeutics Inc. Stock including INR - Dollar returns

The Elicio Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Elicio Therapeutics Inc. investment value today

Current value as on today

₹36,609

Returns

-₹63,391

(-63.39%)

Returns from Elicio Therapeutics Inc. Stock

-₹67,275 (-67.27%)

Dollar Impact

₹3,883 (+3.88%)

Analyst Recommendation on Elicio Therapeutics Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Elicio Therapeutics Inc.. Average target price of $20

Elicio Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Elicio Therapeutics Inc..

What analysts predicted

84.75%UPSIDE

Target Price

$20

Current Price

$3.05

Analyzed by

8 Analysts

Target

$20.00

Elicio Therapeutics Inc. target price $20, a slight upside of 84.75% compared to current price of $3.05. According to 8 analysts rating.

Indian Investors' Interest in Elicio Therapeutics Inc. Stock

Search interest for Elicio Therapeutics Inc. Stock has increased by 96% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 22, 2026 to July 22, 2026

Change:96% versus previous 30 day period

Elicio Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	1	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-9	-10	-10	-10	-13	-10	-10	-8	-8	-10
EBITDA	-8	-11	-6	-18	-13	-10	-10	-9	-7	-11
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-11	-7	-18	-14	-11	-10	-10	-7	-11
Income Tax Expense	0	0	-	-	0	-	-	-	-	-
Net Income	-8	-11	-7	-18	-14	-11	-10	-10	-7	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-1201.03%	0.00%	0.00%	0.00%	0.00%	0.00%

Elicio Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2012	Dec 2013	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	7	6	4	1	2	28	-	-	-	-
Gross Profit	3	3	3	0	1	27	-1	-1	-1	-1
Operating Income	0	0	-14	-38	-55	-39	-23	-35	-44	-37
EBITDA	1	0	-14	-40	-70	-51	-23	-32	-50	-37
Interest Expense	0	0	-	-	8	0	3	1	0	1
Depreciation	-	-	-	0	0	0	0	1	1	1
Income Before Tax	1	1	-20	-40	-80	-54	-28	-35	-51	-39
Income Tax Expense	0	0	-	0	0	0	3	-	-	-
Net Income	0	0	-20	-40	-80	-26	-28	-35	-51	-39
Net Profit Margin	4.21%	9.61%	-497.02%	-2734.23%	-2781.49%	-93.25%	0.00%	0.00%	0.00%	0.00%

Elicio Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-11	-7	-18	-14	-11	-10	-10	-7	-11
Operating Cash Flow	-12	-8	-7	-8	-10	-8	-11	-6	-11
Investing Cash Flow	0	0	0	0	-	-	-	0	-
Financing Cash Flow	11	0	30	0	10	11	9	4	8
Change in Cash	-1	-8	23	-8	0	3	-1	-2	-3

Elicio Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2013	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-20	-40	-80	-26	-28	-35	-51	-39
Operating Cash Flow	1	-8	-24	-22	-23	-22	-32	-37	-36
Investing Cash Flow	0	-	0	0	0	0	0	0	0
Financing Cash Flow	-1	31	4	52	19	21	38	42	36
Change in Cash	0	23	-19	29	-5	-80	5	5	0

Global Institutional Holdings in Elicio Therapeutics Inc.

Funds	Holdings
Northern Trust Corp	0.31%
Knoll Capital Management LP	3.31%
Vanguard Capital Management, LLC	2.72%
Geode Capital Management, LLC	0.71%
Hudson Bay Capital Management LP	0.11%

See all

Insights on Elicio Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 584.7% return, outperforming this stock by 653.7%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 378.9% return, outperforming this stock by 445.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ELTX stock has moved down by -25.6%

About Elicio Therapeutics Inc.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.

Organisation	Elicio Therapeutics Inc.
Headquarters	451 D Street, Boston, MA, United States, 02210
Industry	Biotechnology
CEO	Mr. Robert T. Connelly
E-voting on shares	Click here to vote

Key Management of Elicio Therapeutics Inc.

Name	Title
Ms. Megan C. Filoon	General Counsel, Secretary & Compliance Officer
Ms. Joy Seymour	VP & Head of Regulatory Affairs
Mr. Robert T. Connelly	CEO, President & Director
Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.	Founder & Independent Director
Dr. Christopher M. Haqq M.D., Ph.D.	Executive VP, Head of Research & Development and Chief Medical Officer
Mr. Marc J. Wolfgang M.S.	Chief Technology Officer
Dr. Peter DeMuth Ph.D.	Chief Scientific Officer
Dr. Preetam Shah M.B.A., Ph.D.	Chief Strategy & Financial Officer and Treasurer
Dr. Darrell J. Irvine Ph.D.	Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
Ms. Esther Welkowsky	Senior Vice President of Clinical Development

FAQs

What is Elicio Therapeutics Inc. share price today?

Elicio Therapeutics Inc. share price today is $3.05 as on July 22, 2026 at 10:43 pm IST. Elicio Therapeutics Inc. share today touched a day high of $3.18 and a low of $2.96.

What is the 52 week high and 52 week low for Elicio Therapeutics Inc. share?

Elicio Therapeutics Inc. share touched a 52 week high of $16.00 on June 10, 2026 and a 52 week low of $2.66 on June 16, 2026. Elicio Therapeutics Inc. stock price today i.e. July 22, 2026 at 10:43 pm IST is trending at $3.05,which is 80.94% down from its 52 week high and 14.66% up from its 52 week low.

What is Elicio Therapeutics Inc.'s market capitalisation today?

Elicio Therapeutics Inc. market capitalisation is $0.00T as on July 22, 2026 at 10:43 pm IST.

How to invest in Elicio Therapeutics Inc. Stock (ELTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Elicio Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Elicio Therapeutics Inc. Shares that will get you 0.4918 shares as per Elicio Therapeutics Inc. share price of $3.05 per share as on July 22, 2026 at 10:43 pm IST.

What is the minimum amount required to buy Elicio Therapeutics Inc. Stock (ELTX) from India?

Indian investors can start investing in Elicio Therapeutics Inc. (ELTX) shares with as little as ₹96.565 or $1 (as of July 22, 2026 at 10:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹965.65 in Elicio Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 22, 2026 at 10:43 pm IST). Based on Elicio Therapeutics Inc. share’s latest price of $3.05 as on July 22, 2026 at 10:43 pm IST, you will get 3.2787 shares of Elicio Therapeutics Inc.. Learn more about fractional shares .